Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR vs Oxycodon CR in chronic peripheral neuropathic pain
2011-003628-11Phase 4Terminated
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Neuralgia, postherpetic neuralgia (PHN), polyneuropathy and 2 more comparing Tapentadol PR (Palexia) with Oxycodone CR (Oxygesic) (2 arms). Primary endpoint: Spontaneous intensity of pain (NRS-3). Started Sep 2011; status: terminated.
02
Drugs
tapentadoloxycodone
03
Conditions
Neuralgiapostherpetic neuralgia (PHN)polyneuropathyperipheral nerve injury (PNI)radiculalgia
Beyond the preview
Go deeper on 2011-003628-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003628-11.